Placeholder Content Image

This EU country is the first to trial digital passports

<p dir="ltr">Finland will be the first country to trial digital passports that would allow people to travel without paper documents.</p> <p dir="ltr">Instead, travellers will be able to use a mobile app that stores digital copies of their important travel documents, as reported by the <em><a href="https://www.nzherald.co.nz/travel/finland-set-to-become-the-first-eu-country-to-trial-digital-passports/MDLD7UORHB4GACBOZ35SZ3NUQQ/" target="_blank" rel="noopener">NZ Herald</a></em>.</p> <p dir="ltr">A successful trial would be a big step towards EU-wide adoption of digital passports, but Europeans shouldn’t be ditching their paper passports just yet.</p> <p dir="ltr">Mikko Väisänen, an inspector of the Finnish Border Guard, said the trial is dependent on the Finnish government finishing the drafting of a funding application which will be submitted to the European Commission at the end of the month.</p> <p dir="ltr">Once the funding is approved, a select group of volunteers will be able to take part in the pilot run, held at Helsinki Airport for flights between Finland and Croatia.</p> <p dir="ltr">The volunteers will still need their paper passports, but will be given a mobile app to download onto their phone so they can share the necessary information with border security.</p> <p dir="ltr">Väisänen said that adopting digital passports wouldn’t just make the lives of travellers easier, especially for those who forget or lose their documents while abroad, but can also make border checks more efficient.</p> <p dir="ltr">Christoph Wolff, the Head of Mobility at the World Economic Forum, agreed, saying that electronic, paperless systems could be key to managing demand in airports.</p> <p dir="ltr">"By 2030, international air arrivals are expected to reach 1.8 billion passengers, up 50 per cent from 2016. Under today's systems, airports cannot keep up with this growth," he said.</p> <p dir="ltr">If the Finnish government’s application is successful, the trial would begin at the end of 2022.</p> <p><span id="docs-internal-guid-71dfee4d-7fff-6ba3-056f-0a3907b16c4b"></span></p> <p dir="ltr"><em>Image: Getty Images</em></p>

Travel

Placeholder Content Image

New trials give hope for Parkinson's disease treatment

<p><span style="font-weight: 400;">There has been a breakthrough in treatments for Parkinson’s disease and could spell a potential saving grace after a successful drug trial in Australia. </span></p> <p><span style="font-weight: 400;">The new tests found those with the debilitating disorder improved patients symptoms and aided in stopping the progression of the degenerative disease. </span></p> <p><span style="font-weight: 400;">The drug is giving new hope to those battling Parkinson’s and was developed in Victoria at the Royal Melbourne Hospital. </span></p> <p><span style="font-weight: 400;">Doctor Andrew Evans told </span><a href="https://thenewdaily.com.au/life/wellbeing/2019/06/11/parkinsons-disease-treatment-trial/"><span style="font-weight: 400;">The New Daily</span></a><span style="font-weight: 400;"> the new trial showed a lot of promise for the future of broader treatments. </span></p> <p><span style="font-weight: 400;">“It shows quite a lot of hope,” he said.</span></p> <p><span style="font-weight: 400;">The phase one trials began 15 years ago and the drug was administered to18 Australian Parkinson’s disease patients in three volumes: Small, medium and large. </span></p> <p><span style="font-weight: 400;">The results surprised Dr Evans who expected to see little results however improvements were shown in the patient’s symptoms in addition to them getting “better.”</span></p> <p><span style="font-weight: 400;">“This was more marked in higher-dose groups, who were given 72 milligrams of the drug a day,” he said.</span></p> <p><span style="font-weight: 400;">“I was playing it down to patients at the start, saying, ‘This probably won’t make you feel better’. But people were coming back saying, ‘I feel better on this drug’.”</span></p> <p><span style="font-weight: 400;">In Parkinson’s disease, some neurons in the brain are dead, some are ill and others remain functioning relatively well.</span></p> <p><span style="font-weight: 400;">The improvements and positive findings were a result of the drug activating neurons in the brain. </span></p> <p><span style="font-weight: 400;">“What the drug has done is bring back those sick neurons into functioning well,” Evans said.</span></p> <p><span style="font-weight: 400;">While phase two tests are still underway, researchers are looking to develop more trials focussing on longer periods of time and larger groups of patients.</span></p> <p><span style="font-weight: 400;">“The challenge in Parkinson’s is that it is a very slowly progressing disease,” Dr Evans said.</span></p> <p><span style="font-weight: 400;">“… if you’re just slowing the progress of the disease, you do need to study people for longer.</span></p> <p><span style="font-weight: 400;">“But if this drug holds up … maybe we can get (results) in a shorter amount of time.”</span></p>

Lifestyle